Dr. Acula is a modern hybrid cannabis strain resulting from the crossing of Herijuana and Good Medicine. It is recognized for its high yields and relative growing ease, requiring only 48 days to complete its flowering phase. Suitable for cultivation in both indoor and outdoor environments, the strain presents a moderate level of difficulty for the grower. Its influence on modern cannabis genetics is exemplified by its notable offspring, Sweet Fang.

The terpene profile of Dr. Acula is uniquely complex, led by a dominant concentration of myrcene, followed by caryophyllene, ocimene, and nerolidol. This hierarchy continues with linalool, limonene, pinene, humulene, guaiol, and bisabolol, trailing into minor expressions of eucalyptol, beta-pinene, p-cymene, caryophyllene-oxide, terpinolene, camphene, isopulegol, valencene, borneol, sabinene, and gamma-terpinene. These compounds coalesce to define the strain's specific aromatic identity and sensory nuance.

This THC-dominant hybrid is formulated to induce effects that are consistently reported as relaxed, happy, and uplifted. Due to this pharmacological profile, Dr. Acula is frequently utilized as a therapeutic option for the management of stress, pain, and sleep difficulties. Through its stable genetic contribution to descendants like Sweet Fang, the strain maintains a consistent presence within the contemporary hybrid landscape.